Barsha Baisakhi Nayak

1PUBLICATIONS
8CO-AUTHORS
Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jan 07, 2026
Brepocitinib, a selective TYK2/JAK1 inhibitor, mitigates neutrophilic inflammation and glucocorticoid receptor-β expression in COPD.

Barsha Baisakhi Nayak, Thomas Bärnthaler, Rishi Rajesh

Pageof 1

Frequent Collaborators

1 joint publications

Thomas Bärnthaler

1 joint publications

Rishi Rajesh

1 joint publications

Julia Teppan

1 joint publications

Philipp Douschan

1 joint publications

Anne M van der Does

1 joint publications

Pieter Hiemstra

1 joint publications

Akos Heinemann

1 joint publications

Eva Böhm

Frequent Collaborators

1 joint publications

Thomas Bärnthaler

1 joint publications

Rishi Rajesh

1 joint publications

Julia Teppan

1 joint publications

Philipp Douschan

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

13.7K
See more related videos

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

13.7K
See more related videos